🔎 Trials Near Me

Home › Neuroblastoma

Neuroblastoma clinical trials recruiting in the U.S.

50 studies for Neuroblastoma are recruiting participants at sites across the United States.

Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.

Cities with the most studies

By state

Recently updated studies

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Recruiting
Up to age 17 · All sexes · Updated Nov 13, 2026 · NCT06831552

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Nov 12, 2026 · NCT06541262

Naxitamab Enabled Transplant-Free Study in High-Risk Neuroblastoma

RecruitingPhase 2
Ages 1 to 30 · All sexes · Updated Nov 12, 2026 · NCT07932808

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

RecruitingPhase 2Healthy volunteers welcome
All ages · All sexes · Updated Nov 10, 2026 · NCT04936529

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

RecruitingPhase 2
All ages · All sexes · Updated Nov 9, 2026 · NCT06057948

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

RecruitingObservational study
Ages 4 and older · All sexes · Updated Nov 5, 2026 · NCT01005654

PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy

RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Nov 4, 2026 · NCT04837547

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RecruitingPhase 1/2
6 Months – 25 Years · All sexes · Updated Oct 30, 2026 · NCT06395103

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

RecruitingPhase 2
Up to age 30 · All sexes · Updated Oct 27, 2026 · NCT02605421

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

RecruitingPhase 1
7 Months – 21 Years · All sexes · Updated Oct 27, 2026 · NCT02508038

International PPB/DICER1 Registry

RecruitingObservational studyHealthy volunteers welcome
0 Minutes – 100 Years · All sexes · Updated Oct 26, 2026 · NCT03382158

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

RecruitingObservational studyHealthy volunteers welcome
4 Weeks · All sexes · Updated Oct 16, 2026 · NCT01109394

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

RecruitingPhase 1/2
Ages 1 to 30 · All sexes · Updated Oct 6, 2026 · NCT06721689

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

RecruitingObservational study
All ages · All sexes · Updated Oct 5, 2026 · NCT00588068

MCT for the Harvard/UCSF ROBIN Center

Recruiting
All ages · All sexes · Updated Oct 1, 2026 · NCT06000787

Biomarkers of Resiliency In Childhood Cancer Surgery

RecruitingObservational study
Ages 3 to 25 · All sexes · Updated Sep 14, 2026 · NCT06674811

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

RecruitingPhase 2
Up to age 22 · All sexes · Updated Sep 4, 2026 · NCT02559778

B7-H3.CD28Z.CART in Solid Tumors

RecruitingPhase 1
9 Months – 30 Years · All sexes · Updated Sep 3, 2026 · NCT07358260

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

RecruitingPhase 2
Ages 1 to 21 · All sexes · Updated Sep 3, 2026 · NCT06540963

International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE

RecruitingObservational study
All ages · All sexes · Updated Sep 3, 2026 · NCT03088020

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.